Cytokinetics Inc. buy Royal Bank of Canada
Start price
07.05.25
/
50%
€29.40
Target price
07.05.26
€70.52
Performance (%)
85.37%
Price
13.01.26
€54.50
Summary
This prediction is currently active. With a performance of 85.37% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 07.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 3.810% | 3.810% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Royal Bank of Canada from $82.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.50
11.11.25
11.11.25
€75.30
11.11.26
11.11.26
-1.80%
13.01.26
13.01.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25